- Home
- AKRO vs PRGS Comparison
AKRO vs PRGS Comparison
Compare AKRO & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- PRGS
- Stock Information
- Founded
- AKRO 2017
- PRGS 1981
- Country
- AKRO United States
- PRGS United States
- Employees
- AKRO N/A
- PRGS N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- PRGS Computer Software: Prepackaged Software
- Sector
- AKRO Health Care
- PRGS Technology
- Exchange
- AKRO Nasdaq
- PRGS Nasdaq
- Market Cap
- AKRO 2.8B
- PRGS 2.4B
- IPO Year
- AKRO 2019
- PRGS 1991
- Fundamental
- Price
- AKRO $37.63
- PRGS $56.00
- Analyst Decision
- AKRO Strong Buy
- PRGS Buy
- Analyst Count
- AKRO 9
- PRGS 7
- Target Price
- AKRO $76.29
- PRGS $73.71
- AVG Volume (30 Days)
- AKRO 1.3M
- PRGS 979.3K
- Earning Date
- AKRO 05-09-2025
- PRGS 03-31-2025
- Dividend Yield
- AKRO N/A
- PRGS 0.63%
- EPS Growth
- AKRO N/A
- PRGS N/A
- EPS
- AKRO N/A
- PRGS 1.27
- Revenue
- AKRO N/A
- PRGS $806,739,000.00
- Revenue This Year
- AKRO N/A
- PRGS $30.62
- Revenue Next Year
- AKRO N/A
- PRGS $2.94
- P/E Ratio
- AKRO N/A
- PRGS $44.18
- Revenue Growth
- AKRO N/A
- PRGS 12.85
- 52 Week Low
- AKRO $17.86
- PRGS $48.00
- 52 Week High
- AKRO $58.40
- PRGS $70.56
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- PRGS 49.51
- Support Level
- AKRO $36.46
- PRGS $53.71
- Resistance Level
- AKRO $39.13
- PRGS $58.67
- Average True Range (ATR)
- AKRO 3.04
- PRGS 2.33
- MACD
- AKRO 0.06
- PRGS 0.08
- Stochastic Oscillator
- AKRO 57.38
- PRGS 61.43
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.